These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23962943)

  • 61. Rapid exacerbation of renal function after administration of hydroxyethyl starch in a dog.
    Bae J; Soliman M; Kim H; Kang S; Kim W; Ahn S; Cho K; Choi J; Kim S; Park J; Kim S; DO Y; Yoo J; Yu D
    J Vet Med Sci; 2017 Sep; 79(9):1591-1595. PubMed ID: 28867687
    [TBL] [Abstract][Full Text] [Related]  

  • 62. No more colloid trials!
    Woodcock TE
    Br J Anaesth; 2014 Apr; 112(4):761. PubMed ID: 24645153
    [No Abstract]   [Full Text] [Related]  

  • 63. Anaphylactoid reaction to pentastarch.
    McHugh GJ
    Intensive Care Med; 1999 Jul; 25(7):767-8. PubMed ID: 10470588
    [No Abstract]   [Full Text] [Related]  

  • 64. Should clinical studies guide clinical practice?
    Hartog C
    Swiss Med Wkly; 2012; 142():w13657. PubMed ID: 22847777
    [No Abstract]   [Full Text] [Related]  

  • 65. Molecular size and origin do not influence the harmful side effects of hydroxyethyl starch on human proximal tubule cells (HK-2) in vitro.
    Bruno RR; Neuhaus W; Roewer N; Wunder C; Schick MA
    Anesth Analg; 2014 Sep; 119(3):570-577. PubMed ID: 25010825
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Trauma experts urge cautious use of i.v. fluids.
    Traynor K
    Am J Health Syst Pharm; 2012 Nov; 69(21):1846, 1848. PubMed ID: 23111663
    [No Abstract]   [Full Text] [Related]  

  • 67. Lack of nephrotoxicity by 6% hydroxyethyl starch 130/0.4 during hip arthroplasty: a randomized controlled trial.
    Kancir AS; Pleckaitiene L; Hansen TB; Ekeløf NP; Pedersen EB
    Anesthesiology; 2014 Nov; 121(5):948-58. PubMed ID: 25127210
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Volume replacement with hydroxyethyl starch: is there an influence on kidney function?].
    Suttner S; Boldt J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):71-7. PubMed ID: 14767795
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Gosling P; Rittoo D; Manji M; Mahmood A; Vohra R
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526921
    [No Abstract]   [Full Text] [Related]  

  • 70. EMA recommendation to suspend HES is hazardous.
    Annane D; Fuchs-Buder T; Zoellner C; Kaukonen M; Scheeren TWL
    Lancet; 2018 Feb; 391(10122):736-738. PubMed ID: 29449011
    [No Abstract]   [Full Text] [Related]  

  • 71. [Not Available].
    Hahn R
    Lakartidningen; 2018 May; 115():. PubMed ID: 29738050
    [No Abstract]   [Full Text] [Related]  

  • 72. Anaphylaxis to starch.
    Ebo DG; Schuerwegh A; Stevens WJ
    Allergy; 2000 Nov; 55(11):1098-9. PubMed ID: 11097329
    [No Abstract]   [Full Text] [Related]  

  • 73. [Decision of the European Medicines Agency on hydroxyethyl starch : Important step towards therapeutic and legal security].
    Zwissler B; Rossaint R
    Anaesthesist; 2013 Nov; 62(11):869-70. PubMed ID: 24275932
    [No Abstract]   [Full Text] [Related]  

  • 74. [EMA-decision on HES-restrictions].
    Svensén C; Hjelmqvist H
    Lakartidningen; 2014 Jan 8-14; 111(1-2):20. PubMed ID: 24498715
    [No Abstract]   [Full Text] [Related]  

  • 75. Hetastarch in perioperative volume expansion.
    Alexander JC
    Chest; 2003 Oct; 124(4):1194-6. PubMed ID: 14555545
    [No Abstract]   [Full Text] [Related]  

  • 76. Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.
    Patel A; Waheed U; Brett SJ
    Intensive Care Med; 2013 Aug; 39(8):1507-8. PubMed ID: 23736140
    [No Abstract]   [Full Text] [Related]  

  • 77. Should hydroxyethyl starch solutions be totally banned?
    Vincent JL; Kellum JA; Shaw A; Mythen MG
    Crit Care; 2013 Oct; 17(5):193. PubMed ID: 24083341
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of 6% hydroxyethyl starch and 5% albumin for volume replacement therapy in patients undergoing cystectomy (CHART): study protocol for a randomized controlled trial.
    Kammerer T; Klug F; Schwarz M; Hilferink S; Zwissler B; von Dossow V; Karl A; Müller HH; Rehm M
    Trials; 2015 Aug; 16():384. PubMed ID: 26314293
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reply to the editor.
    Navickis RJ; Haynes GR; Wilkes MM
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):310-1. PubMed ID: 23244264
    [No Abstract]   [Full Text] [Related]  

  • 80. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Godet G
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526922
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.